Genetic gene mutations: Opening new therapeutic avenues in metastatic prostate cancer


(Vall d’Hebron Institute of Oncology) International study shows the prognostic and predictive value of DNA-repair gene mutations in more precisely selecting standard therapies for the treatment of metastatic prostate cancer.